FDA grants orphan status to Emergent's anthrax vaccine

April 22, 2014

Emergent Biosolutions Inc. (EBS) said the U.S. Food and Drug Administration has granted orphan-drug status to its BioThrax treatment for patients suspected or confirmed to have been exposed to anthrax.

Click here for the article.

Share This Story

Back